DRKS00024735CompletedNot Applicable
Risk factors and therapy strategies of a first line treatment failure after invasive fungal infections
niversitätsklinikum Heidelberg0 sites180 target enrollmentStarted: April 9, 2021Last updated:
Conditions
Trial Snapshot
- Phase
- Not Applicable
- Status
- Completed
- Sponsor
- Enrollment
- 180
Study Overview
Brief Summary
No summary available.
Study Design
- Study Type
- Observational
Eligibility Criteria
- Ages
- 18 Years to one (—)
- Sex
- All
Inclusion Criteria
- •Since this is a purely retrospective data analysis, there is no recruitment of patients; rather, patient records are screened to identify suitable records for analysis. The data sets are drawn from the files of patients who suffered from invasive candidiasis [candidemia, intra-abdominal candidiasis (IAC)], invasive aspergillosis (IA), invasive pulmonary aspergillosis (IPA) or any other invasive infection between January 2006 and December 2016 with rare fungal species suffered. In addition, patients should be included who only have a positive galactomannan test (Aspergillus-Ag positive) or a culture of Aspergillus spp. and for whom aspiration (inhalation of food components, e.g. through vomiting) was suspected.
- •With regard to microbiological data: Only information on microbiological data from existing patient files is collected. In the absence of information, no additional samples will be obtained for the study. There is no patient contact.
Exclusion Criteria
- •no specific exclusion criteria
Investigators
Similar Trials
Not yet recruiting
Unknown
The risk factors, signs and symptoms, and treatment options for classical and hypervirulent Klebsiella pneumonia infections in hospitalized patientsCTRI/2023/11/060277Dr. Souvik Chaudhuri, Dr. Nagendra Babu Danavath
Not yet recruiting
Not Applicable
Risk factors, clinical profile and management of non- oliguric hyperkalemia in preterm neonates less than 32 weeks- An observational studyCTRI/2022/04/041680nil
Withdrawn
Not Applicable
Causes, risk factors, complications and treatment of uveitis in childhoodintraocular inflammation1000269310003816NL-OMON32456niversitair Medisch Centrum Utrecht75
Not yet recruiting
Unknown
Risk factors for the development and severity of interstitial lung disease associated with EGFR tyrosine kinase inhibitors in non-small cell lung cancer: a systematic review and meta-analysisEGFR tyrosine kinase inhibitor-associated interstitial lung diseaseJPRN-UMIN000050523Showa University
Recruiting
Not Applicable
Analysis of risk factors and development of prevention and treatment programs on obesity and combined metabolic disordersEndocrine, nutritional and metabolic diseaseKCT0000903Korea Centers for Disease Control and Prevention467